TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective

Briana G. Nixon(Memorial Sloan Kettering Cancer Center), Ming O. Li(Memorial Sloan Kettering Cancer Center)
Nature reviews. Immunology
November 15, 2022
10.1038/s41577-022-00796-z
Cited by 139

Related Papers

Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
|Cold Spring Harbor Perspectives in Biology|2017|606
Novel Foxo1-dependent transcriptional programs control Treg cell function
|Nature|2012|406
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
|Cell|2016|349
Reprogramming tumour-associated macrophages to outcompete cancer cells
|Nature|2023|138
Glycolysis Fuels Phosphoinositide 3-Kinase Signaling to Bolster T Cell Immunity
|bioRxiv (Cold Spring Harbor Laboratory)|2020|25